454 related articles for article (PubMed ID: 27609792)
1. Impact of
Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R; Cooper S; Chen Z; Schuster DM
J Nucl Med; 2017 Mar; 58(3):412-418. PubMed ID: 27609792
[TBL] [Abstract][Full Text] [Related]
2. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856
[TBL] [Abstract][Full Text] [Related]
3. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
[TBL] [Abstract][Full Text] [Related]
4. Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.
Akin-Akintayo OO; Jani AB; Odewole O; Tade FI; Nieh PT; Master VA; Bellamy LM; Halkar RK; Zhang C; Chen Z; Goodman MM; Schuster DM
Clin Nucl Med; 2017 Jan; 42(1):e22-e28. PubMed ID: 27749412
[TBL] [Abstract][Full Text] [Related]
5. Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (
Dhere VR; Schuster DM; Goyal S; Schreibmann E; Hershatter BW; Rossi PJ; Shelton JW; Patel PR; Jani AB
Int J Radiat Oncol Biol Phys; 2022 Aug; 113(5):1003-1014. PubMed ID: 35417762
[TBL] [Abstract][Full Text] [Related]
6.
Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M; Master VA; Joshi SS; Kucuk O; Carthon BC; Bilen MA; Abiodun-Ojo OA; Akintayo AA; Dhere VR; Schuster DM
Lancet; 2021 May; 397(10288):1895-1904. PubMed ID: 33971152
[TBL] [Abstract][Full Text] [Related]
7. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
8. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?
Livsey JE; Wylie JP; Swindell R; Khoo VS; Cowan RA; Logue JP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1076-81. PubMed ID: 15519777
[TBL] [Abstract][Full Text] [Related]
9. Utility of
Galgano SJ; McDonald AM; Rais-Bahrami S; Porter KK; Choudhary G; Burgan C; Bhambhvani P; Nix JW; Morgan DE; Li Y; Thomas JV; McConathy J
AJR Am J Roentgenol; 2021 Sep; 217(3):720-729. PubMed ID: 33052718
[No Abstract] [Full Text] [Related]
10. Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on
Abiodun-Ojo OA; Jani AB; Akintayo AA; Akin-Akintayo OO; Odewole OA; Tade FI; Joshi SS; Master VA; Fielder B; Halkar RK; Zhang C; Goyal S; Goodman MM; Schuster DM
J Nucl Med; 2021 Aug; 62(8):1089-1096. PubMed ID: 33517323
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
Wahart A; Guy JB; Vallard A; Geissler B; Ben Mrad M; Falk AT; Prevot N; de Laroche G; Rancoule C; Chargari C; Magné N
Br J Radiol; 2016; 89(1058):20150579. PubMed ID: 26648528
[TBL] [Abstract][Full Text] [Related]
12. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P
Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
Kim EH; Siegel BA; Teoh EJ; Andriole GL;
Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
[TBL] [Abstract][Full Text] [Related]
14. Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design.
Jani AB; Fox TH; Whitaker D; Schuster DM
Clin Nucl Med; 2009 May; 34(5):279-84. PubMed ID: 19387202
[TBL] [Abstract][Full Text] [Related]
15. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
Su A; Blend MJ; Spelbring D; Hamilton RJ; Jani AB
Clin Nucl Med; 2006 Mar; 31(3):139-44. PubMed ID: 16495731
[TBL] [Abstract][Full Text] [Related]
16. Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy.
Jani AB; Spelbring D; Hamilton R; Blend MJ; Pelizzari C; Brendler C; Krauz L; Vijayakumar S; Sapra B; Weichselbaum RR
J Nucl Med; 2004 Feb; 45(2):238-46. PubMed ID: 14960642
[TBL] [Abstract][Full Text] [Related]
17. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
[TBL] [Abstract][Full Text] [Related]
18. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
[TBL] [Abstract][Full Text] [Related]
19. Implementing intensity modulated radiotherapy to the prostate bed: dosimetric study and early clinical results.
Riou O; Laliberté B; Azria D; Menkarios C; Llacer Moscardo C; Dubois JB; Aillères N; Fenoglietto P
Med Dosim; 2013; 38(2):117-21. PubMed ID: 23237661
[TBL] [Abstract][Full Text] [Related]
20. A PET/MRI study towards finding the optimal [
Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Tessem MB; Moestue SA; Bertilsson H; Bathen TF
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):695-703. PubMed ID: 27817158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]